VERTEX PHARMACEUTICALS INC / MA Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for November 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 25 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 94,400 | |
Nov 25 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 133.88 | 200 | 26,776 | 265,284 | 265.5 K to 265.3 K (-0.08 %) |
Nov 25 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 132.81 | 2,000 | 265,620 | 265,484 | 267.5 K to 265.5 K (-0.75 %) |
Nov 25 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 131.98 | 8,200 | 1,082,236 | 267,484 | 275.7 K to 267.5 K (-2.97 %) |
Nov 25 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 275,684 | 265.3 K to 275.7 K (+3.92 %) |
Nov 23 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Gift | G | 0.00 | 80,000 | 0 | 265,284 | 345.3 K to 265.3 K (-23.17 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 63.14 | 7,500 | 473,550 | 7,500 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 72.14 | 7,500 | 541,050 | 12,500 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 130.00 | 15,000 | 1,950,000 | 75,000 | 90 K to 75 K (-16.67 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 63.14 | 7,500 | 473,550 | 90,000 | 82.5 K to 90 K (+9.09 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 72.14 | 7,500 | 541,050 | 82,500 | 75 K to 82.5 K (+10.00 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 130.00 | 16,125 | 2,096,250 | 217,902 | 234 K to 217.9 K (-6.89 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 10,315 | 758,256 | 30,938 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 130.00 | 10,315 | 1,340,950 | 100,562 | 110.9 K to 100.6 K (-9.30 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 10,315 | 758,256 | 110,877 | 100.6 K to 110.9 K (+10.26 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Option Exercise | M | 57.27 | 12,500 | 715,875 | 0 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Sell | S | 130.15 | 12,500 | 1,626,875 | 1,088 | 13.6 K to 1.1 K (-91.99 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | MCGLYNN MARGARET G | Director | Buy | M | 57.27 | 12,500 | 715,875 | 13,588 | 1.1 K to 13.6 K (+1,148.90 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 104,800 | |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 133.03 | 400 | 53,212 | 345,284 | 345.7 K to 345.3 K (-0.12 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 132.44 | 3,300 | 437,052 | 345,684 | 349 K to 345.7 K (-0.95 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 131.55 | 3,100 | 407,805 | 348,984 | 352.1 K to 349 K (-0.88 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 130.25 | 800 | 104,200 | 352,084 | 352.9 K to 352.1 K (-0.23 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 128.96 | 2,800 | 361,088 | 352,884 | 355.7 K to 352.9 K (-0.79 %) |
Nov 20 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 355,684 | 345.3 K to 355.7 K (+3.01 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 122.28 | 85 | 10,394 | 78,963 | 79 K to 79 K (-0.11 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 123.00 | 1 | 123 | 14,937 | 14.9 K to 14.9 K (-0.01 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 122.31 | 127 | 15,533 | 14,938 | 15.1 K to 14.9 K (-0.84 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 3,650 | 282,182 | 38,250 | |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.00 | 3,650 | 452,600 | 104,464 | 108.1 K to 104.5 K (-3.38 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.00 | 100 | 12,300 | 108,114 | 108.2 K to 108.1 K (-0.09 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 122.47 | 143 | 17,513 | 108,214 | 108.4 K to 108.2 K (-0.13 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 121.95 | 184 | 22,439 | 108,357 | 108.5 K to 108.4 K (-0.17 %) |
Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 3,650 | 282,182 | 108,541 | 104.9 K to 108.5 K (+3.48 %) |
Nov 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 115,200 | |
Nov 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 119.34 | 1,200 | 143,208 | 345,284 | 346.5 K to 345.3 K (-0.35 %) |
Nov 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 118.49 | 9,200 | 1,090,108 | 346,484 | 355.7 K to 346.5 K (-2.59 %) |
Nov 13 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 355,684 | 345.3 K to 355.7 K (+3.01 %) |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 600 | 46,386 | 41,900 | |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 45.11 | 5,664 | 255,503 | 28,320 | |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 125.17 | 200 | 25,034 | 104,748 | 104.9 K to 104.7 K (-0.19 %) |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.59 | 1,220 | 152,000 | 104,948 | 106.2 K to 104.9 K (-1.15 %) |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.04 | 2,400 | 295,296 | 106,168 | 108.6 K to 106.2 K (-2.21 %) |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 122.46 | 2,444 | 299,292 | 108,568 | 111 K to 108.6 K (-2.20 %) |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 600 | 46,386 | 111,012 | 110.4 K to 111 K (+0.54 %) |
Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 45.11 | 5,664 | 255,503 | 110,412 | 104.7 K to 110.4 K (+5.41 %) |
Nov 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 125,600 | |
Nov 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 125.85 | 200 | 25,170 | 345,284 | 345.5 K to 345.3 K (-0.06 %) |
Nov 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 124.92 | 4,300 | 537,156 | 345,484 | 349.8 K to 345.5 K (-1.23 %) |
Nov 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 124.05 | 3,200 | 396,960 | 349,784 | 353 K to 349.8 K (-0.91 %) |
Nov 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 123.22 | 2,700 | 332,694 | 352,984 | 355.7 K to 353 K (-0.76 %) |
Nov 06 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 355,684 | 345.3 K to 355.7 K (+3.01 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Option Exercise | M | 53.85 | 20,000 | 1,077,000 | 0 | |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Sell | S | 127.62 | 2,100 | 268,002 | 5,265 | 7.4 K to 5.3 K (-28.51 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Sell | S | 126.91 | 6,708 | 851,312 | 7,365 | 14.1 K to 7.4 K (-47.67 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Sell | S | 125.98 | 9,592 | 1,208,400 | 14,073 | 23.7 K to 14.1 K (-40.53 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Sell | S | 125.09 | 700 | 87,563 | 23,665 | 24.4 K to 23.7 K (-2.87 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Sell | S | 123.66 | 900 | 111,294 | 24,365 | 25.3 K to 24.4 K (-3.56 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | ULLIAN ELAINE | Director | Buy | M | 53.85 | 20,000 | 1,077,000 | 25,265 | 5.3 K to 25.3 K (+379.87 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,334 | 76,398 | 26,000 | |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 126.98 | 500 | 63,490 | 625 | 1.1 K to 625 (-44.44 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 125.93 | 525 | 66,113 | 1,125 | 1.7 K to 1.1 K (-31.82 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 123.64 | 100 | 12,364 | 1,650 | 1.8 K to 1.7 K (-5.71 %) |
Nov 04 2015 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,334 | 76,398 | 1,750 | 416 to 1.8 K (+320.67 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 126.61 | 1,100 | 139,271 | 78,963 | 80.1 K to 79 K (-1.37 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 126.01 | 2,638 | 332,414 | 80,063 | 82.7 K to 80.1 K (-3.19 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 124.94 | 1,500 | 187,410 | 82,701 | 84.2 K to 82.7 K (-1.78 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 123.34 | 700 | 86,338 | 84,201 | 84.9 K to 84.2 K (-0.82 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 126.62 | 2,685 | 339,975 | 107,784 | 110.5 K to 107.8 K (-2.43 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 125.98 | 4,865 | 612,893 | 110,469 | 115.3 K to 110.5 K (-4.22 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 124.95 | 2,800 | 349,860 | 115,334 | 118.1 K to 115.3 K (-2.37 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 126.31 | 4,500 | 568,395 | 104,748 | 109.2 K to 104.7 K (-4.12 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 125.30 | 3,950 | 494,935 | 109,248 | 113.2 K to 109.2 K (-3.49 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.44 | 1,000 | 124,440 | 113,198 | 114.2 K to 113.2 K (-0.88 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.36 | 900 | 111,024 | 114,198 | 115.1 K to 114.2 K (-0.78 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 126.86 | 200 | 25,372 | 233,923 | 234.1 K to 233.9 K (-0.09 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 126.31 | 8,125 | 1,026,269 | 234,123 | 242.2 K to 234.1 K (-3.35 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 125.35 | 4,800 | 601,680 | 242,248 | 247 K to 242.2 K (-1.94 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 124.33 | 1,400 | 174,062 | 247,048 | 248.4 K to 247 K (-0.56 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 123.34 | 1,600 | 197,344 | 248,448 | 250 K to 248.4 K (-0.64 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 126.64 | 500 | 63,320 | 14,937 | 15.4 K to 14.9 K (-3.24 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 126.04 | 1,638 | 206,454 | 15,437 | 17.1 K to 15.4 K (-9.59 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 124.98 | 900 | 112,482 | 17,075 | 18 K to 17.1 K (-5.01 %) |
Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 123.37 | 400 | 49,348 | 17,975 | 18.4 K to 18 K (-2.18 %) |